Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetes: Diabetes, Obesity and Metabolism

F. Prattichizzo, A. Giuliani, J. Sabbatinelli, G. Matacchione, D. Ramini, A.R. Bonfigli, M.R. Rippo, P. de Candia, A.D. Procopio, F. Olivieri, A. Ceriello

Research output: Contribution to journalArticlepeer-review

Abstract

Residual inflammatory risk (RIR) is defined as persistent circulating levels of high sensitivity C-reactive protein (hs-CRP) >2 mg/L despite an optimal (
Original languageEnglish
Pages (from-to)1696-1700
Number of pages5
JournalDiabetes Obes. Metab.
Volume22
Issue number9
DOIs
Publication statusPublished - 2020

Keywords

  • body mass index, cardiovascular diseases, c-reactive protein, diabetes complications, ischaemic heart disease, LDL-cholesterol, obesity, residual inflammatory risk, type 2 diabetes, waist-hip ratio
  • C reactive protein
  • cholesterol
  • glinide derivative
  • glucose
  • hydroxymethylglutaryl coenzyme A reductase inhibitor
  • insulin
  • low density lipoprotein cholesterol
  • metformin
  • oral antidiabetic agent
  • sulfonylurea derivative
  • triacylglycerol
  • unclassified drug
  • aged
  • Article
  • body mass
  • cardiovascular disease
  • cholesterol blood level
  • cohort analysis
  • controlled study
  • diabetic nephropathy
  • diabetic neuropathy
  • diabetic retinopathy
  • drug use
  • female
  • glycemic control
  • high risk patient
  • human
  • inflammation
  • insulin resistance
  • kidney failure
  • major clinical study
  • male
  • non insulin dependent diabetes mellitus
  • obesity
  • peripheral vascular disease
  • prevalence
  • protein blood level
  • residual inflammatory risk
  • retrospective study
  • triacylglycerol blood level
  • waist hip ratio

Fingerprint Dive into the research topics of 'Prevalence of residual inflammatory risk and associated clinical variables in patients with type 2 diabetes: Diabetes, Obesity and Metabolism'. Together they form a unique fingerprint.

Cite this